上海口腔医学 ›› 2026, Vol. 35 ›› Issue (5): 449-455.doi: 10.19439/j.sjos.2026.05.001

• 论著 • 上一篇    下一篇

变异链球菌灌胃对小鼠血压及肠道代谢物的影响

王瑞雪1,2, 徐烁1, 段胜仲2, 周薇2   

  1. 1.上海交通大学医学院附属第九人民医院 牙周病科,2.口腔微生态与系统性疾病实验室,上海交通大学口腔医学院,国家口腔医学中心,国家口腔疾病临床医学研究中心,上海市口腔医学重点实验室,上海市口腔医学研究所,上海 200011
  • 收稿日期:2025-06-13 修回日期:2025-07-22 发布日期:2026-11-05
  • 通讯作者: 周薇,E-mail: sweetzw@hotmail.com
  • 作者简介:王瑞雪(1998—),女,硕士,住院医师,E-mail: wrxxfdx@163.com
  • 基金资助:
    国家自然科学基金(81991503)

Effect of oral gavage of Streptococcus mutans on blood pressure and intestinal metabolites in mice

Wang Ruixue1,2, Xu Shuo1, Duan Shengzhong2, Zhou Wei2   

  1. 1. Department of Periodontology, 2. Laboratory of Microbiota and Systemic Diseases, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology; Shanghai Research Institute of Stomatology. Shanghai 200011, China
  • Received:2025-06-13 Revised:2025-07-22 Published:2026-11-05

摘要: 目的: 分析口腔致龋菌变异链球菌(Streptococcus mutans, S. mutans)灌胃对人血管紧张素Ⅱ诱导的高血压小鼠血压及肠道代谢物的影响,鉴定与高血压相关的肠道代谢标志物。方法: 将8周龄C57BL/6J雄鼠随机分为(vehicle hypertension, VH)组和(S. mutans hypertension, SH)组,分别用200 μL无菌1×磷酸盐缓冲液(phosphate buffer solution, PBS)或含有1×109 CFU S. mutans的PBS灌胃,每天1次,共4周。再用微小渗透压泵皮下输注人血管紧张素Ⅱ(750 ng/kg/min)2周,诱导小鼠高血压模型,期间用无创袖尾法检测小鼠血压。2周后收集两组小鼠粪便,利用液相色谱-串联质谱(liquid chromatography-tandem mass spectrometry determination, LC-MS/MS)非靶向代谢组学技术检测小鼠肠道代谢物。结果: 无创袖尾法血压检测表明,与VH组小鼠相比,SH组小鼠收缩压和舒张压升高。粪便LC-MS/MS非靶向代谢组学分析结果表明,VH组小鼠和SH组小鼠之间共有237种差异代谢物,15种具有显著差异,主要属于脂类和类脂分子、有机酸及其衍生物。错误发现率(false discovery rate, FDR)<0.05的代谢通路有6条,富集水平最高的代谢通路是细菌ATP结合盒转运体通路,该通路与肠道屏障、肠道代谢物的生成有关。结论: S. mutans灌胃能显著改变高血压小鼠肠道代谢物的组成,可能通过调节胆碱-三甲胺代谢轴、一氧化氮生成、活性氧生成等途径升高血管紧张素Ⅱ诱导的小鼠高血压。

关键词: 变异链球菌, 高血压, 血管紧张素Ⅱ, 肠道代谢组学

Abstract: PURPOSE: To analyze the effects of S.mutans gavage on blood pressure and intestinal metabolites in angiotensin Ⅱ-induced hypertensive mice, and to identify intestinal metabolic markers associated with hypertension. METHODS: Eight-week-old male C57BL/6J mice were randomly divided into vehicle hypertension(VH) group and S. mutans hypertension(SH) group, each administered with 200 μL sterile PBS or PBS containing 1×109 CFU S.mutans by gavage once daily for 4 weeks. Subsequently, a mouse model of hypertension was induced by subcutaneous infusion of human angiotensin Ⅱ(750 ng/kg/min) for 2 weeks using a mini-osmotic pump, during which the blood pressure of the mice was monitored by non-invasive tail-cuff method. After 2 weeks, feces from both groups of mice were collected, and the intestinal metabolites of the mice were detected by LC-MS/MS untargeted metabolomics technology. RESULTS: Non-invasive tail-cuff blood pressure monitoring showed that compared with the VH group, the systolic and diastolic blood pressures of the SH group were elevated. The results of non-targeted metabolomic analysis of feces by LC-MS/MS showed that there were 237 differential metabolites between the two groups, among which 15 showed significant differences, mainly belonging to lipids and lipid-like molecules, organic acids and their derivatives. There were 6 significantly enriched metabolic pathways (FDR<0.05), with the most enriched pathway being the bacterial ATP-binding cassette transporter pathway, which was related to the intestinal barrier and the generation of intestinal metabolites. CONCLUSIONS: Gavage of S.mutans can significantly alter the composition of intestinal metabolites in hypertensive mice, potentially increasing angiotensin Ⅱ-induced hypertension in mice by modulating the choline-trimethylamine metabolic axis, NO production, and ROS production.

Key words: S. mutans, Hypertension, Angiotensin Ⅱ, Gut metabolomics

中图分类号: